pre-IPO PHARMA

COMPANY OVERVIEW

Aura Biosciences is developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach called molecular surgery. By safely eliminating cancer locally, doctors can treat early and transform the lives of people with a wide range of cancers that are poorly managed today.


LOCATION

  • Cambridge, MA, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://www.aurabiosciences.com/


    CAREER WEBSITE

    https://www.aurabiosciences.com/careers/


    SOCIAL MEDIA


    INVESTORS

    The estate of Henri Termeer advent-life-sciences alexandria-venture-investments chiesi-ventures columbus-venture-partners li-cor-biosciences lundbeckfonden ysios-capital


    PRESS RELEASES


    Oct 28, 2021

    Aura Biosciences Announces Pricing of Initial Public Offering


    Oct 11, 2021

    Aura Biosciences Presents Interim Phase 2 Safety Data Evaluating Suprachoroidal Administration of AU-011 in Patients with Choroidal Melanoma at the ASRS 2021 Annual Meeting


    Sep 29, 2021

    Aura Biosciences Expands Executive Leadership Team and Board of Directors


    Jun 17, 2021

    Aura Biosciences Assembles New Bladder Cancer Focused Scientific Advisory Board


    Jun 8, 2021

    Aura Biosciences Appoints Sapna Srivastava, Ph.D., to its Board of Directors


    For More Press Releases


    Google Analytics Alternative